Pines Wealth Management LLC Takes $274,000 Position in The Cigna Group (NYSE:CI)

Pines Wealth Management LLC bought a new stake in The Cigna Group (NYSE:CI - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 981 shares of the health services provider's stock, valued at approximately $274,000.

Other large investors have also made changes to their positions in the company. AQR Capital Management LLC raised its position in The Cigna Group by 63.4% in the 2nd quarter. AQR Capital Management LLC now owns 1,547,245 shares of the health services provider's stock valued at $510,467,000 after purchasing an additional 600,215 shares during the last quarter. Ameriprise Financial Inc. increased its stake in shares of The Cigna Group by 23.4% in the second quarter. Ameriprise Financial Inc. now owns 2,138,193 shares of the health services provider's stock valued at $706,822,000 after buying an additional 405,694 shares in the last quarter. The Manufacturers Life Insurance Company raised its holdings in shares of The Cigna Group by 145.3% in the second quarter. The Manufacturers Life Insurance Company now owns 683,361 shares of the health services provider's stock valued at $225,899,000 after buying an additional 404,791 shares during the last quarter. International Assets Investment Management LLC lifted its position in The Cigna Group by 49,287.7% during the 3rd quarter. International Assets Investment Management LLC now owns 400,040 shares of the health services provider's stock worth $138,590,000 after buying an additional 399,230 shares in the last quarter. Finally, Skandinaviska Enskilda Banken AB publ grew its holdings in The Cigna Group by 526.3% during the 2nd quarter. Skandinaviska Enskilda Banken AB publ now owns 363,537 shares of the health services provider's stock worth $120,174,000 after acquiring an additional 305,490 shares during the last quarter. Institutional investors own 86.99% of the company's stock.

The Cigna Group Trading Down 1.2 %

NYSE CI traded down $3.52 during trading on Thursday, reaching $281.06. 1,474,957 shares of the stock traded hands, compared to its average volume of 1,445,727. The Cigna Group has a fifty-two week low of $262.03 and a fifty-two week high of $370.83. The company has a quick ratio of 0.72, a current ratio of 0.72 and a debt-to-equity ratio of 0.71. The firm has a market cap of $78.18 billion, a price-to-earnings ratio of 26.52, a price-to-earnings-growth ratio of 0.75 and a beta of 0.54. The stock's 50-day moving average price is $303.49 and its 200 day moving average price is $327.70.

The Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.22 by $0.29. The company had revenue of $63.70 billion during the quarter, compared to analyst estimates of $59.58 billion. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The firm's revenue was up 29.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $6.77 EPS. Analysts predict that The Cigna Group will post 28.5 EPS for the current year.

The Cigna Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, December 19th. Investors of record on Wednesday, December 4th were paid a dividend of $1.40 per share. The ex-dividend date was Wednesday, December 4th. This represents a $5.60 dividend on an annualized basis and a yield of 1.99%. The Cigna Group's payout ratio is 52.83%.

Analysts Set New Price Targets

A number of brokerages have weighed in on CI. Piper Sandler reiterated an "overweight" rating and set a $394.00 target price (up from $392.00) on shares of The Cigna Group in a research report on Tuesday, November 5th. Royal Bank of Canada decreased their price objective on The Cigna Group from $384.00 to $377.00 and set an "outperform" rating on the stock in a research report on Friday, November 1st. Barclays lifted their target price on The Cigna Group from $405.00 to $420.00 and gave the company an "overweight" rating in a research note on Tuesday, November 5th. StockNews.com cut The Cigna Group from a "strong-buy" rating to a "buy" rating in a report on Monday, November 4th. Finally, Deutsche Bank Aktiengesellschaft lowered their price objective on The Cigna Group from $398.00 to $394.00 and set a "buy" rating for the company in a research report on Monday, November 4th. One research analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, The Cigna Group presently has a consensus rating of "Buy" and a consensus price target of $395.93.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.